It is generally believed that hyperlipidemia occurring with obesity may increase cardiac lipid uptake and formation of ceramides, DAG and other lipids, which initially activates membrane-bound Nadph oxidases (NOXs) to generate ROS13, 15, 16. The gene discussed is FMO5; the disease is obesity disorder.